Frontlight ResearchEarly access
Colorectal cancer trials in Italy
111 of 157 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Milan, Rome, Rozzano
- Age
- 18 years and over
- People
- 623 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - Phase 1/2Taking peopleA Phase 1/2 Study of IAM1363 in HER2 Cancers
- Where
- Florence, Milan, Naples
- Age
- 18 years and over
- People
- 463 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 · EU 2024-519188-17-00 - Phase 1/2Taking peopleBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Where
- Ancona, Candiolo (TO), Meldola (FC), Milan, Misterbianco (CT), Naples, Rozzano
- Age
- 18 years and over
- People
- 910 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06324357 - Phase 1/2Taking peopleA Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- Where
- Milan
- Age
- 18 years and over
- People
- 47 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07213609 - Phase 2Not yet taking people in ItalyA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
- Where
- Milan, Naples, Rome, Rozzano
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00 - Phase 3Taking peopleCAPRI-3 Phase 3 clinical study to evaluate the use of continuing cetuximab treatment beyond first line progression in molecular selected metastatic colorectal cancer patients
- Where
- Ancona, Avellino, Aviano, Bari, Brescia, Castellana Grotte, Catania, Catanzaro, Florence, Lecce, Meldola, Milan, Mirabella Eclano, Naples, Negrar, Padova, Palermo, Pisa, Reggio Emilia, Rome, Rozzano, San Giovanni Rotondo, Sassari, Statte, Tricase
- Age
- 18 years and over
- People
- 360 worldwide
- Run by
- Gruppo Oncologico Dell'Italia Meridionale
See details and how to join2024-519322-20-00 - Phase 3Not yet taking people in ItalyStudy of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
- Where
- Ancona, Avellino, Florence, Meldola, Milan, Naples, Pisa, Ravenna, Reggio Emilia, Rome, Rozzano, San Giovanni Rotondo, Tricase, Udine
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Genmab A/S
See details and how to join2026-525883-17-00 - Phase 3Taking peopleA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Where
- Candiolo, Leghorn, Milan, Monserrato, Naples, Padova, Perugia, Ravenna, Rozzano, Verona
- Age
- 18 years and over
- People
- 477 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00 - Phase 2Not yet taking people in ItalyNeoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Where
- Milan, Naples, Pisa
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Solstice Oncology, Inc.
See details and how to joinNCT07808151 · EU 2026-527233-58-00 - Phase 1Taking peopleSTART: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
- Where
- Candiolo, Milan, Naples, Rozzano
- Age
- 18 years and over
- People
- 15 worldwide
- Run by
- Valo Therapeutics Oy
See details and how to joinNCT05492682 · EU 2024-517580-23-00 - Phase 1Taking peopleA Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Where
- Meldola, Milan, Naples, Padova, Rome
- Age
- 18 years and over
- People
- 542 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT04929223 · EU 2023-505163-37-00 - Phase 3Taking peoplePhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Where
- Aviano, Brescia, Florence, Genova, Meldola, Milan, Pisa, Roma, Verona
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07228832 - Phase 3Taking peopleA Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Where
- Castellana Grotte, Milan, Naples, Padova, Pisa, Reggio Emilia, Rome
- Age
- 18 years and over
- People
- 1,020 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412 · EU 2025-524648-37-00 - Phase 1Taking peopleA Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Milan
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Milan, Reggio Emilia, Rome
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - Phase 1/2Taking peopleA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Where
- Milan, Pisa
- Age
- 18 years and over
- People
- 225 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05379595 · EU 2023-506517-22-00 - Phase 3Taking peopleA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Where
- Faenza, Lugo, Milan, Padova, Pisa, Ravenna, Rozzano
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06662786 · EU 2024-513852-13-00 - Phase 3Taking peopleA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Where
- Candiolo, Catania, Florence, Milan, Padova, Pisa, Rozzano
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00 - Phase 1/2Taking peopleA Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Where
- Milan
- Age
- 18 years and over
- People
- 560 worldwide
- Run by
- Genmab
See details and how to joinNCT03526835 · EU 2024-513627-16-01 - No phaseTaking peopleArtificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp Histology
- Where
- Rozzano
- Age
- 40 years and over
- People
- 1,800
- Run by
- Istituto Clinico Humanitas
See details and how to joinNCT06041945 - Phase 1/2Taking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Rome
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Where
- Ancona, Aviano, Bari, Brescia, Candiolo, Milan, Naples, Padova, Pisa, Ravenna, Reggio Emilia, Rome, Rozzano, San Giovanni Rotondo, Verona
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00 - Phase 1/2Taking peopleA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Milan, Rome
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - Phase 1/2Taking peopleBOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Milan, Naples, Pisa
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00 - Phase 2Taking peopleA Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Where
- Milan, Naples, Padova, Pisa, Rome, Rozzano, Turin
- Age
- 18 years and over
- People
- 390 worldwide
- Run by
- AbbVie
See details and how to joinNCT06820463 · EU 2024-512981-33-00